A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7
Reads0
Chats0
TLDR
In this article, a 7-item anxiety scale (GAD-7) had good reliability, as well as criterion, construct, factorial, and procedural validity, and increasing scores on the scale were strongly associated with multiple domains of functional impairment.Abstract:
Background Generalized anxiety disorder (GAD) is one of the most common mental disorders; however, there is no brief clinical measure for assessing GAD. The objective of this study was to develop a brief self-report scale to identify probable cases of GAD and evaluate its reliability and validity. Methods A criterion-standard study was performed in 15 primary care clinics in the United States from November 2004 through June 2005. Of a total of 2740 adult patients completing a study questionnaire, 965 patients had a telephone interview with a mental health professional within 1 week. For criterion and construct validity, GAD self-report scale diagnoses were compared with independent diagnoses made by mental health professionals; functional status measures; disability days; and health care use. Results A 7-item anxiety scale (GAD-7) had good reliability, as well as criterion, construct, factorial, and procedural validity. A cut point was identified that optimized sensitivity (89%) and specificity (82%). Increasing scores on the scale were strongly associated with multiple domains of functional impairment (all 6 Medical Outcomes Study Short-Form General Health Survey scales and disability days). Although GAD and depression symptoms frequently co-occurred, factor analysis confirmed them as distinct dimensions. Moreover, GAD and depression symptoms had differing but independent effects on functional impairment and disability. There was good agreement between self-report and interviewer-administered versions of the scale. Conclusion The GAD-7 is a valid and efficient tool for screening for GAD and assessing its severity in clinical practice and research.read more
Citations
More filters
Journal ArticleDOI
Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study
Gabrielle Campbell,Wayne Hall,Wayne Hall,Amy Peacock,Nicholas Lintzeris,Raimondo Bruno,Briony Larance,Suzanne Nielsen,Milton Cohen,Gary C. K. Chan,Richard P. Mattick,Fiona M. Blyth,Marian Shanahan,Timothy Dobbins,Michael Farrell,Louisa Degenhardt,Louisa Degenhardt +16 more
TL;DR: People who used cannabis had greater pain and lower self-efficacy in managing pain, and there was no evidence that cannabis use reduced pain severity or interference or exerted an opioid-sparing effect.
Journal ArticleDOI
Transdiagnostic versus disorder-specific and clinician-guided versus self-guided internet-delivered treatment for generalized anxiety disorder and comorbid disorders: A randomized controlled trial
Blake F. Dear,Lauren G. Staples,Matthew D. Terides,Eyal Karin,Judy Zou,Luke Johnston,Milena Gandy,Vincent J. Fogliati,Bethany M. Wootton,Peter M. McEvoy,Nickolai Titov +10 more
TL;DR: Large reductions in symptoms of GAD and comorbid major depressive disorder andComorbid social anxiety disorder and panic disorder were found across the conditions, highlighting the public health potential of carefully developed TD-C BT and SG-CBT.
Journal ArticleDOI
Modelling the contribution of the Big Five personality traits, health anxiety, and COVID-19 psychological distress to generalised anxiety and depressive symptoms during the COVID-19 pandemic.
TL;DR: Extraversion, agreeableness, and conscientiousness were negatively associated with the three mediators, which, in turn, were positively associated with generalised anxiety and depressive symptoms, with COVID-19 anxiety showing the strongest effect.
Journal ArticleDOI
Development and Psychometric Validation of the EDE-QS, a 12 Item Short Form of the Eating Disorder Examination Questionnaire (EDE-Q)
Nicole Gideon,Nick Hawkes,Jonathan Mond,Jonathan Mond,Rob Saunders,Kate Tchanturia,Lucy Serpell,Lucy Serpell +7 more
TL;DR: A 12-item short form of the Eating Disorder Examination Questionnaire Short is derived, a brief, reliable and valid measure of eating disorder symptom severity that performs similarly to the EDE-Q and that lends itself for the use of sessional outcome monitoring in treatment and research.
Journal ArticleDOI
Exposure to COVID-19 pandemic stress: Associations with depression and anxiety in emerging adults in the United States.
TL;DR: The Pandemic Stress Questionnaire (PSQ) was developed and tested its psychometric properties, characterized experiences in emerging adults, and examined associations with internalizing symptoms.
References
More filters
Journal ArticleDOI
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.
John E. Ware,Cathy D. Sherbourne +1 more
TL;DR: A 36-item short-form survey designed for use in clinical practice and research, health policy evaluations, and general population surveys to survey health status in the Medical Outcomes Study is constructed.
Journal ArticleDOI
The PHQ-9: validity of a brief depression severity measure.
TL;DR: In addition to making criteria-based diagnoses of depressive disorders, the PHQ-9 is also a reliable and valid measure of depression severity, which makes it a useful clinical and research tool.
Journal ArticleDOI
An inventory for measuring clinical anxiety: psychometric properties.
TL;DR: Un nouvel inventaire auto-administre destine a mesurer l'anxiete pathologique, le «Beck Anxiety Cheklist» (BAI) est decrit, evalue et compare au «Hamilton Anxiety Rating Scale» (test avec lequel des correlations moderees sont trouvees).
Journal ArticleDOI
The validity of the Hospital Anxiety and Depression Scale: An updated literature review
TL;DR: HADS was found to perform well in assessing the symptom severity and caseness of anxiety disorders and depression in both somatic, psychiatric and primary care patients and in the general population.